NASH (Non-Alcoholic Steatohepatitis) is a Chronic Liver Disease that Affects Millions Globally – Interview

NASH (Non-Alcoholic Steatohepatitis) is a Chronic Liver Disease that Affects Millions Globally – Interview

International NASH Day on June 12th, 2020

will be dedicated to increasing awareness of NASH (non-alcoholic steatohepatitis). NASH is the progressive form of nonalcoholic fatty liver disease (NAFLD) and affects more than 115 million people worldwide with about 20 million impacted in the US. An estimated 357 million people will be affected by 2030.

International NASH Day will highlight actions people can take to prevent, identify, and treat the disease. NASH often progresses without easily visible symptoms and is commonly not identified before it becomes life-threatening.

It is critical that the general public, at-risk patients, the medical community, public health authorities, policymakers, and the media learn more about NASH and associated diseases, such as liver cancer, that are becoming more prevalent in our society.

As public health safety concerns surrounding COVID-19 continue,

the Global Liver Institute reviewed the situation and solicited extensive advice before concluding that this year’s International NASH Day will be transformed and presented through virtual events via a global social media campaign co-hosted with partners around the world.

NAFLD and NASH are major risk factors for concurrent conditions: more than 70% of patients are obese, up to 75% have type 2 diabetes, and anywhere from 20-80% have hyperlipidemia. NASH may lead to cirrhosis, liver cancer, and liver transplant.

This year, International NASH Day is more important than ever during this time of coronavirus crisis. NASH remains poorly understood and under-diagnosed.

There are currently limited treatment options

available for people living with NASH but lifestyle changes can have an impact on slowing NASH progression or even reversing the disease if identified early.

The Fatty Liver Foundation (FLF) aims to address, educate, coordinate, and support victims of the growing epidemic of fatty liver disease. FLF also offers information and support to those who have become ill as they cope with all stages of the liver disease.

Join me in a recent interview

with  Wayne Eskridge, Founder of the Fatty Liver Foundation and cirrhosis patient, along with Donna Cryer, President and CEO of the Global Liver Institute, as they were available to discuss the significance of International NASH Day and the virtual events to mark the day. They will also talk about the mission, duty, and purpose of the Fatty Liver Foundation to educate, coordinate, and support victims of the growing epidemic of fatty liver disease.

Listen to the entire interview here.

For more information, go to:

BIO-Donna R. Cryer, JD,  is the founder and CEO of the Global Liver Institute (GLI), the only patient-driven liver health non-profit operating in the US and Europe. She has channeled her personal experience as an IBD patient and  25-year liver transplant recipient into professional advocacy across a career in law, policy, consulting, public relations, clinical trial recruitment, and nonprofit management. Donna is a graduate of Harvard-Radcliffe Colleges and Georgetown University Law Center.

GLI convenes the NASH Council, Liver Cancers Council, International NASH Day(TM),and the Advanced Advocacy Academy, equipping liver patients to be effective advocates. @globalliver

BIO-Wayne Eskridge, Fatty Liver Foundation President and CEO 
Wayne Eskridge, an electrical engineering graduate from the University of Idaho, worked in software and electronics through a 50-year professional career. He served in many technical and managerial roles beginning as a computer programmer, through multiple levels of technical and managerial positions in businesses of all sizes. He held executive positions in both public and private corporations with worldwide responsibilities, and from startups to Fortune 500 firms. 

In 2015 Wayne was diagnosed with stage 4 NASH with cirrhosis. He had no symptoms and didn’t know that his diet, typical of so many Americans, was unhealthy and damaging to his liver. As a result of his own experiences, he became aware of an acute need for educational resources for patients. While there is currently no medical treatment for NAFLD/NASH, lifestyle changes can be effective. Wayne believes that prevention through education is the only practical solution today. His desire to help others avoid his experiences led him to the decision to become a patient champion and to create the Fatty Liver Foundation. 

Interview courtesy: Fatty Liver Foundation & Global Liver Institute






[mailerlite_form form_id=1]

Cynthia Tait

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: